Completed
SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Type of Sarcoma:
Metastatic Leiomyosarcoma
Drug:
Mocetinostat & Gemcitabine
Accrual Status:
Completed
Overall Study Principal Investigator:
Shreyas Patel, MD
Co-Principal Investigator
MD Anderson Cancer Center
Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology
Co-Principal Investigator
MD Anderson Cancer Center
Edwin Choy, MD, PhD
Co-Principal Investigator
MGH, Dana Farber/Harvard Cancer Center
Division of Hematology Oncology